Menu Menu


GSK Financials       Clear


GSK        0001131399    
Filing Date Form Type Description Document
2022-02-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-24 6-K CANADA APPROVAL FOR MEDICAGO GSK COVID-19 VACCINE View Document
2022-02-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-22 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-22 6-K GSK CONSUMER HEALTHCARE TO BE CALLED HALEON View Document
2022-02-18 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-18 6-K GSK GIVES UPDATE ON RSV MATERNAL VACCINE CANDIDATE View Document
2022-02-17 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-17 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-17 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-17 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-17 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-16 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-14 SC 13G SC 13G View Document
2022-02-14 6-K TRANSFER OF TREASURY SHARES View Document
2022-02-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-10 SC 13G/A AMENDMENT TO SC 13G View Document
2022-02-10 SC 13G SCHEDULE 13G View Document
2022-02-10 SC 13G/A AMENDMENT TO SC 13G View Document
2022-02-10 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2022-02-10 SC 13G/A AMENDMENT TO FORM SC 13G View Document
2022-02-10 6-K BENLYSTA APPROVED IN CHINA FOR LUPUS NEPHRITIS View Document
2022-02-09 6-K FINAL RESULTS View Document
2022-02-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-02-07 SC 13G/A View Document
2022-02-07 6-K PUBLICATION OF FULL YEAR 2021 RESULTS View Document
2022-02-02 6-K GSK ANNOUNCES SETTLEMENT BETWEEN VIIV AND GILEAD View Document
2022-02-01 6-K FDA APPROVES VIIV HEALTHCARE'S SNDA FOR CABENUVA View Document
2022-02-01 6-K TOTAL VOTING RIGHTS View Document
2022-01-26 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-01-20 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-01-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-01-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-01-19 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-01-19 6-K TONY WOOD APPOINTED CSO DESIGNATE, GSK View Document
2022-01-18 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-01-18 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-01-18 6-K UPDATE - GSK CONSUMER HEALTHCARE View Document
2022-01-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-01-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-01-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2022-01-11 6-K US GOVT BUYS ADDITIONAL 600,000 SOTROVIMAB DOSES View Document
2022-01-04 6-K TOTAL VOTING RIGHTS View Document
2021-12-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-12-22 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-12-21 6-K VIIV HEALTHCARE ANNOUNCES FDA APPROVAL OF APRETUDE View Document
2021-12-20 6-K CONSUMER HEALTHCARE CHAIR DESIGNATE APPOINTED View Document
2021-12-17 6-K XEVUDY APPROVED IN EUROPE TO TREAT COVID-19 View Document
2021-12-15 6-K GSK/SANOFI COVID-19 VACCINE BOOSTER & PH3 UPDATE View Document
2021-12-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-12-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-12-07 6-K MEDICAGO/GSK COVID-19 VACCINE POSITIVE PH3 DATA View Document
2021-12-07 6-K SOTROVIMAB RETAINS ITS ACTIVITY VS OMICRON VARIANT View Document
2021-12-02 6-K SOTROVIMAB RETAINS ITS ACTIVITY VS OMICRON VARIANT View Document
2021-12-01 6-K TOTAL VOTING RIGHTS View Document
2021-11-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-11-24 6-K GSK PUBLISHES PROVISIONAL 2022 DIVIDEND DATES View Document
2021-11-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-11-17 6-K NUCALA APPROVED IN EUROPE FOR MORE INDICATIONS View Document
2021-11-15 6-K BLOCK LISTING INTERIM REVIEW View Document
2021-11-12 6-K PHASE III IM ADMINISTRATION DATA FOR SOTROVIMAB View Document
2021-11-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-11-10 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-11-05 6-K GSK SHARES POSITIVE PHASE III DATA FOR DAPRODUSTAT View Document
2021-11-01 6-K TOTAL VOTING RIGHTS View Document
2021-10-27 6-K 3RD QUARTER RESULTS View Document
2021-10-27 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-27 6-K DIRECTORATE CHANGE View Document
2021-10-15 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-14 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-12 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-10-01 6-K TOTAL VOTING RIGHTS View Document
2021-09-27 SC 13G/A AMENDMENT TO FORM SC 13G View Document
2021-09-24 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-22 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-20 6-K DIRECTOR DECLARATION View Document
2021-09-16 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2021-09-16 SC 13D/A AMENDMENT TO FORM SC 13D View Document
2021-09-13 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-09 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-08 UPLOAD View Document
2021-09-07 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-03 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-09-01 6-K TOTAL VOTING RIGHTS View Document
2021-08-31 CORRESP View Document
2021-08-31 6-K SK BIO & GSK START PH3 COVID-19 VACCINE TRIAL View Document
2021-08-25 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-08-23 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-08-18 UPLOAD View Document
2021-08-13 6-K/A DIRECTOR/PDMR SHAREHOLDING - AMENDMENT View Document
2021-08-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document
2021-08-11 6-K DIRECTOR/PDMR SHAREHOLDING View Document

Find registration statements, periodic reports, and other forms by typing ticker symbol of a company.

Ticker:

Search company filings and access detailed reports including 10-K, 10-Q, 8-K, and other critical filings. Stay informed on corporate disclosures, regulatory filings, and updates with our easy-to-use EDGAR API filings search tool.



We can also help with your taxes.

Formal Tax

www.formal.tax





(402) 804-8293


Formal Financial App
Google Play - Apple Store

created using: Admin Canvas